Meridian Wealth Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$154K Sell
2022
Q3
$210K Hold
2022
Q2
$142K Sell
2022
Q1
$467K Hold
2021
Q4
$416K Hold
2021
Q3
$415K Buy
2021
Q2
$279K Buy
2021
Q1
$193K Buy